- Home
- MNKD vs WLFC Comparison
MNKD vs WLFC Comparison
Compare MNKD & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- WLFC
- Stock Information
- Founded
- MNKD 1991
- WLFC 1985
- Country
- MNKD United States
- WLFC United States
- Employees
- MNKD N/A
- WLFC N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- WLFC Industrial Specialties
- Sector
- MNKD Health Care
- WLFC Consumer Discretionary
- Exchange
- MNKD Nasdaq
- WLFC Nasdaq
- Market Cap
- MNKD 1.2B
- WLFC 1.2B
- IPO Year
- MNKD 2004
- WLFC 1996
- Fundamental
- Price
- MNKD $5.54
- WLFC $149.03
- Analyst Decision
- MNKD Buy
- WLFC
- Analyst Count
- MNKD 6
- WLFC 0
- Target Price
- MNKD $10.33
- WLFC N/A
- AVG Volume (30 Days)
- MNKD 5.3M
- WLFC 56.2K
- Earning Date
- MNKD 08-06-2025
- WLFC 11-03-2025
- Dividend Yield
- MNKD N/A
- WLFC 0.67%
- EPS Growth
- MNKD 149.32
- WLFC 30.03
- EPS
- MNKD 0.11
- WLFC 16.84
- Revenue
- MNKD $301,736,000.00
- WLFC $637,163,000.00
- Revenue This Year
- MNKD $14.52
- WLFC $16.17
- Revenue Next Year
- MNKD $12.81
- WLFC $4.88
- P/E Ratio
- MNKD $50.97
- WLFC $8.80
- Revenue Growth
- MNKD 21.48
- WLFC 32.40
- 52 Week Low
- MNKD $3.38
- WLFC $97.54
- 52 Week High
- MNKD $7.63
- WLFC $235.43
- Technical
- Relative Strength Index (RSI)
- MNKD 72.22
- WLFC 50.48
- Support Level
- MNKD $5.22
- WLFC $143.39
- Resistance Level
- MNKD $6.20
- WLFC $157.55
- Average True Range (ATR)
- MNKD 0.26
- WLFC 4.92
- MACD
- MNKD 0.18
- WLFC -0.98
- Stochastic Oscillator
- MNKD 73.17
- WLFC 39.55
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About WLFC Willis Lease Finance Corporation
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.